Latest Articles
- If it ain’t broke, what are we trying to fix? Reprocessing devices labeled“for single use only”
A new FDA rule will enrich the manufacturers of medical devices and saddle us with another layer of bureaucracy. All to fix a nonexistent problem.
- Osteoarthritis: No cure, but many options for symptom relief
For most patients, management options consist of nonpharmacologic and pharmacologic therapy Disease-modifying drugs may be on the horizon.
- Vaginitis: Finding the cause prevents treatment failure
To diagnose and manage vaginitis, there is no substitute for performing a physical and microscopic examination.
- Diabetic gastropathy: A practical approach to a vexing problem
A stepwise approach can improve symptoms and quality of life while providing adequate nutrition.
- Heparin-induced thrombocytopenia: How to manage it, how to avoid it
What to do when heparin paradoxically causes the very problem it is given to prevent.
- Of rice, grain, and zeal: Lessons from Drs. Kempner and Esselstyn
Two physicians who successfully motivated their patients to make lifestyle changes were true believers.
- Rosacea: An update
Early diagnosis and thoughtful management help control the disease and minimize discomfort and emotional distress.
What is the appropriate initial dose of corticosteroids to treat giant cell arteritis?A lower dose than traditionally used may be enough to control symptoms and prevent blindness while minimizing adverse effects.
- Maximizing antihypertensive management in the elderly
A checklist of specific considerations when treating hypertension in the elderly.
- Fibrinolytic therapy in the elderly: Making sense of troubling new findings
Do patients older than 75 years with acute MI benefit from fibrinolytic therapy? For now, we have to live with uncertainty.